CV Sciences, Inc. (CVSI)
About CV Sciences, Inc.
CV SCIENCES INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $13.8M
- Net income
- -$958.0K
- Total assets
- $7.0M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
CV Sciences, Inc. (CVSI) Stock Price
- Reported a net loss of $958.0K in FY2025.
- Trading 78% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CV Sciences, Inc..
Write a review
News about CV Sciences, Inc.
News & sentiment via Polygon.io
CV Sciences, Inc.: frequently asked questions
Is CV Sciences, Inc. an American company?
CV Sciences, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is CV Sciences, Inc. headquartered?
CV Sciences, Inc. is headquartered in San Diego, California, United States.
Is CV Sciences, Inc. publicly traded?
Yes — CV Sciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol CVSI on the OTC.
What does CV Sciences, Inc. do?
CV Sciences, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.